Búsqueda | Biblioteca Virtual en Salud

1.

Overall Disability Response Score: An integrated endpoint to assess disability improvement and worsening over time in patients with multiple sclerosis.

Chang, Ih; Kappos, Ludwig; Giovannoni, Gavin; Calabresi, Peter A; Sandrock, Alfred; Cheng, Wenting; Xiao, Shan; Riester, Katherine; Belachew, Shibeshih; Deykin, Aaron; Zhu, Bing.

Mult Scler ; 28(14): 2263-2273, 2022 12.

Artículo en Inglés | MEDLINE | ID: mdl-36131595

2.

Temporal profile of serum neurofilament light in multiple sclerosis: Implications for patient monitoring.

Calabresi, Peter A; Arnold, Douglas L; Sangurdekar, Dipen; Singh, Carol M; Altincatal, Arman; de Moor, Carl; Engle, Bob; Goyal, Jaya; Deykin, Aaron; Szak, Suzanne; Kieseier, Bernd C; Rudick, Richard A; Plavina, Tatiana.

Mult Scler ; 27(10): 1497-1505, 2021 09.

Artículo en Inglés | MEDLINE | ID: mdl-33307998

3.

Dual A1/A2B Receptor Blockade Improves Cardiac and Renal Outcomes in a Rat Model of Heart Failure with Preserved Ejection Fraction.

Tofovic, Stevan P; Salah, Eman M; Smits, Glenn J; Whalley, Eric T; Ticho, Barry; Deykin, Aaron; Jackson, Edwin K.

J Pharmacol Exp Ther ; 356(2): 333-40, 2016 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-26585572

4.

Analysis of peginterferon ß-1a exposure and Gd-enhanced lesion or T2 lesion response in relapsing-remitting multiple sclerosis patients.

Hang, Yaming; Hu, Xiao; Zhang, Jie; Liu, Shifang; Deykin, Aaron; Nestorov, Ivan.

J Pharmacokinet Pharmacodyn ; 43(4): 371-83, 2016 08.

Artículo en Inglés | MEDLINE | ID: mdl-27299457

5.

Peginterferon beta-1a in multiple sclerosis: 2-year results from ADVANCE.

Kieseier, Bernd C; Arnold, Douglas L; Balcer, Laura J; Boyko, Alexey A; Pelletier, Jean; Liu, Shifang; Zhu, Ying; Seddighzadeh, Ali; Hung, Serena; Deykin, Aaron; Sheikh, Sarah I; Calabresi, Peter A.

Mult Scler ; 21(8): 1025-35, 2015 Jul.

Artículo en Inglés | MEDLINE | ID: mdl-25432952

6.

Pharmacokinetics and pharmacodynamics of peginterferon beta-1a in patients with relapsing-remitting multiple sclerosis in the randomized ADVANCE study.

Hu, Xiao; Cui, Yue; White, Joleen; Zhu, Ying; Deykin, Aaron; Nestorov, Ivan; Hung, Serena.

Br J Clin Pharmacol ; 79(3): 514-22, 2015 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-25265472

7.

Effect of peginterferon beta-1a on MRI measures and achieving no evidence of disease activity: results from a randomized controlled trial in relapsing-remitting multiple sclerosis.

Arnold, Douglas L; Calabresi, Peter A; Kieseier, Bernd C; Sheikh, Sarah I; Deykin, Aaron; Zhu, Ying; Liu, Shifang; You, Xiaojun; Sperling, Bjoern; Hung, Serena.

BMC Neurol ; 14: 240, 2014 Dec 31.

Artículo en Inglés | MEDLINE | ID: mdl-25551571

8.

An open-label, multicenter study to evaluate the safe and effective use of the single-use autoinjector with an Avonex® prefilled syringe in multiple sclerosis subjects.

Phillips, J Theodore; Fox, Edward; Grainger, William; Tuccillo, Dianne; Liu, Shifang; Deykin, Aaron.

BMC Neurol ; 11: 126, 2011 Oct 14.

Artículo en Inglés | MEDLINE | ID: mdl-21999176

9.

Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial.

Cadavid, Diego; Mellion, Michelle; Hupperts, Raymond; Edwards, Keith R; Calabresi, Peter A; Drulovic, Jelena; Giovannoni, Gavin; Hartung, Hans-Peter; Arnold, Douglas L; Fisher, Elizabeth; Rudick, Richard; Mi, Sha; Chai, Yi; Li, Jie; Zhang, Yiwei; Cheng, Wenting; Xu, Lei; Zhu, Bing; Green, Susan M; Chang, Ih; Deykin, Aaron; Sheikh, Sarah I.

Lancet Neurol ; 18(9): 845-856, 2019 09.

Artículo en Inglés | MEDLINE | ID: mdl-31285147

10.

Daily versus as-needed corticosteroids for mild persistent asthma.

Boushey, Homer A; Sorkness, Christine A; King, Tonya S; Sullivan, Sean D; Fahy, John V; Lazarus, Stephen C; Chinchilli, Vernon M; Craig, Timothy J; Dimango, Emily A; Deykin, Aaron; Fagan, Joanne K; Fish, James E; Ford, Jean G; Kraft, Monica; Lemanske, Robert F; Leone, Frank T; Martin, Richard J; Mauger, Elizabeth A; Pesola, Gene R; Peters, Stephen P; Rollings, Nancy J; Szefler, Stanley J; Wechsler, Michael E; Israel, Elliot.

N Engl J Med ; 352(15): 1519-28, 2005 Apr 14.

Artículo en Inglés | MEDLINE | ID: mdl-15829533

11.

Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension.

Kapoor, Raju; Ho, Pei-Ran; Campbell, Nolan; Chang, Ih; Deykin, Aaron; Forrestal, Fiona; Lucas, Nisha; Yu, Bei; Arnold, Douglas L; Freedman, Mark S; Goldman, Myla D; Hartung, Hans-Peter; Havrdová, Eva Kubala; Jeffery, Douglas; Miller, Aaron; Sellebjerg, Finn; Cadavid, Diego; Mikol, Dan; Steiner, Deborah.

Lancet Neurol ; 17(5): 405-415, 2018 05.

Artículo en Inglés | MEDLINE | ID: mdl-29545067

12.

Advances in lung transplantation for patients who have cystic fibrosis.

Goldberg, Hilary J; Deykin, Aaron.

Clin Chest Med ; 28(2): 445-57, 2007 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-17467559

13.

Population-Based Pharmacokinetic and Exposure-Efficacy Analyses of Peginterferon Beta-1a in Patients With Relapsing Multiple Sclerosis.

Hu, Xiao; Hang, Yaming; Cui, Yue; Zhang, Jie; Liu, Shifang; Seddighzadeh, Ali; Deykin, Aaron; Nestorov, Ivan.

J Clin Pharmacol ; 57(8): 1005-1016, 2017 08.

Artículo en Inglés | MEDLINE | ID: mdl-28394418

14.

Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial.

Israel, Elliot; Chinchilli, Vernon M; Ford, Jean G; Boushey, Homer A; Cherniack, Reuben; Craig, Timothy J; Deykin, Aaron; Fagan, Joanne K; Fahy, John V; Fish, James; Kraft, Monica; Kunselman, Susan J; Lazarus, Stephen C; Lemanske, Robert F; Liggett, Stephen B; Martin, Richard J; Mitra, Nandita; Peters, Stephen P; Silverman, Eric; Sorkness, Christine A; Szefler, Stanley J; Wechsler, Michael E; Weiss, Scott T; Drazen, Jeffrey M.

Lancet ; 364(9444): 1505-12, 2004.

Artículo en Inglés | MEDLINE | ID: mdl-15500895

15.

Pegylated interferon ß-1a for relapsing-remitting multiple sclerosis (ADVANCE): a randomised, phase 3, double-blind study.

Calabresi, Peter A; Kieseier, Bernd C; Arnold, Douglas L; Balcer, Laura J; Boyko, Alexey; Pelletier, Jean; Liu, Shifang; Zhu, Ying; Seddighzadeh, Ali; Hung, Serena; Deykin, Aaron.

Lancet Neurol ; 13(7): 657-65, 2014 Jul.

Artículo en Inglés | MEDLINE | ID: mdl-24794721

16.

Prostanoid DP receptor variants and asthma.

Deykin, Aaron.

N Engl J Med ; 352(8): 837-8; author reply 837-8, 2005 Feb 24.

Artículo en Inglés | MEDLINE | ID: mdl-15736293

17.

Targeting biologic markers in asthma--is exhaled nitric oxide the bull's-eye?

Deykin, Aaron.

N Engl J Med ; 352(21): 2233-5, 2005 May 26.

Artículo en Inglés | MEDLINE | ID: mdl-15914549

18.

Pharmacokinetics of oral tonapofylline and its acyl-glucuronide metabolite in patients with mild and moderate hepatic impairment.

Li, Zhaoyang; Gan, Liang-Shang; Marbury, Thomas; Lasseter, Kenneth C; Natarajan, Amy; Stecher, Scott; Wei, Dong; Yang, Liyu; Freedman, Daniel; Deykin, Aaron.

J Clin Pharmacol ; 52(4): 543-51, 2012 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-21610206

19.

Dose titration of intramuscular interferon beta-1a reduces the severity and incidence of flu-like symptoms during treatment initiation.

Matson, Mark A; Zimmerman, Thomas R; Tuccillo, Dianne; Tang, Yongqiang; Deykin, Aaron.

Curr Med Res Opin ; 27(12): 2271-8, 2011 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-21988668

20.

Effects of BG9928, an adenosine A1 receptor antagonist, in patients with congestive heart failure.

Gottlieb, Stephen S; Ticho, Barry; Deykin, Aaron; Abraham, William T; Denofrio, David; Russell, Stuart D; Chapman, Douglas; Smith, William; Goldman, Steven; Thomas, Ignatius.

J Clin Pharmacol ; 51(6): 899-907, 2011 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-20926754

Biblioteca Virtual en Salud

Hipertensión

Su selección (0)

Formato de exportación:

Exportar: